Terri Smith‐Weller

发表

Glutathione S-transferase M1, T1, and P1 Polymorphisms and Parkinson's Disease

W. Longstreth, P. Stapleton, D. Eaton, 2003, Neuroscience Letters.

The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease

H. Checkoway, L. Costa, G. Franklin, 2000, Neuroscience Letters.

Pesticides and Risk of Parkinson Disease

H. Checkoway, W. Longstreth, G. Franklin, 2004 .

Outcome of surgery for thoracic outlet syndrome in Washington state workers’ compensation

G. Franklin, D. Fulton-Kehoe, Terri Smith‐Weller, 2000, Neurology.

Environmental tobacco smoke and Parkinson's disease

H. Checkoway, W. Longstreth, G. Franklin, 2012, Movement disorders : official journal of the Movement Disorder Society.

The functional polymorphism of the hemoglobin‐binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease

H. Checkoway, W. Longstreth, G. Franklin, 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Calcium channel blockers and β-blockers in relation to Parkinson's disease

W. Kukull, S. Heckbert, H. Checkoway, 2007 .

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.

H. Checkoway, W. Longstreth, G. Franklin, 2006, Parkinsonism & related disorders.

Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.

H. Checkoway, W. Longstreth, G. Franklin, 2009, Parkinsonism & related disorders.

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

Harvey Checkoway, W. Longstreth, H. Checkoway, 2002, American journal of epidemiology.

Patient satisfaction, treatment experience, and disability outcomes in a population-based cohort of injured workers in Washington State: implications for quality improvement.

J. Turner, G. Franklin, D. Fulton-Kehoe, 2004, Health services research.

Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

H. Checkoway, L. Costa, G. Franklin, 2000, Journal of neurology, neurosurgery, and psychiatry.

Dietary factors in Parkinson's disease: The role of food groups and specific foods

H Checkoway, H. Checkoway, S. Beresford, 1999, Movement disorders : official journal of the Movement Disorder Society.

Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease

W. Kukull, S. Heckbert, H. Checkoway, 2006, Movement disorders : official journal of the Movement Disorder Society.

Pesticides and risk of Parkinson disease: a population-based case-control study.

W. Longstreth, H. Checkoway, G. Franklin, 2005, Archives of neurology.

A communitywide intervention to improve outcomes and reduce disability among injured workers in Washington State.

J. Turner, G. Franklin, D. Fulton-Kehoe, 2004, The Milbank quarterly.

Improving the Quality of Care for Injured Workers in Washington State: Challenges and Approaches to Incorporating Best Occupational Practices on a Community-Wide Level

J. Turner, G. Franklin, D. Fulton-Kehoe, 2003 .

Formulations of hormone therapy and risk of Parkinson's disease

B. Racette, H. Checkoway, W. Longstreth, 2014, Movement disorders : official journal of the Movement Disorder Society.

Occupational factors and risk of Parkinson's disease: A population-based case-control study.

H. Checkoway, W. Longstreth, G. Franklin, 2009, American journal of industrial medicine.

Improving Quality, Preventing Disability and Reducing Costs in Workers' Compensation Healthcare: A Population-based Intervention Study

G. Franklin, J. Gluck, D. Fulton-Kehoe, 2011, Medical care.

Use of Attorneys and Appeal Filing in the Washington State Workers’ Compensation Program: Does Patient Satisfaction Matter?

J. Turner, G. Franklin, D. Fulton-Kehoe, 2004, Journal of occupational and environmental medicine.

DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls

H. Checkoway, W. Longstreth, C. Brefel‐Courbon, 2004, Movement disorders : official journal of the Movement Disorder Society.

Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes

W. Longstreth, H. Checkoway, W. Longstreth, 2003, Neurology.

Genetic polymorphisms of superoxide dismutase in Parkinson's disease

H. Checkoway, G. Franklin, J. Kushleika, 2001, Movement disorders : official journal of the Movement Disorder Society.

MR nerve imaging in a prospective cohort of patients with suspected carpal tunnel syndrome

P. Heagerty, D. Haynor, M. Kliot, 2002, Neurology.

Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.

H. Checkoway, L. Costa, G. Franklin, 1998, American journal of medical genetics.

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

H. Checkoway, L. Costa, G. Franklin, 1998, Neurology.

No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes

W. Longstreth, P. Stapleton, H. Checkoway, 2005, Neuroscience Letters.

Occupational hearing loss in Washington state, 1984-1991: II. Morbidity and associated costs.

W. Daniell, G. Franklin, D. Fulton-Kehoe, 1998, American journal of industrial medicine.

Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

H. Checkoway, L. Costa, G. Franklin, 2000, Journal of neurology, neurosurgery, and psychiatry.

Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease.

W. Longstreth, H. Checkoway, G. Franklin, 2001, Pharmacogenetics.